Medicare
The Issue
“Medicare for All” these days – a catch-all label that has become a part of the political dialogue – represents a variety of health coverage proposals that would do everything from establish a national health insurance program with no competition to create a public, Medicare-like option…
On Aug. 2, the Centers for Medicare & Medicaid Services issued its fiscal year (FY) 2020 final rule for the inpatient and long-term care hospital prospective payment systems (PPS). This advisory covers the rule’s LTCH-related provisions. AHA issued a separate Regulatory Advisory on the…
The Centers for Medicare & Medicaid Services July 29 issued a proposed rule that would update physician fee schedule payments for calendar year (CY) 2020.
This supplemental report updates a previous analysis to reflect the revised Medicare-X Choice legislation as introduced in April, 2019.
Medicare will cover nationally Chimeric Antigen Receptor T-cell therapies approved by the Food and Drug Administration to treat certain cancers, as well as off-label uses recommended by compendia approved by the Centers for Medicare & Medicaid Services.
Offering a government insurance program reimbursing at Medicare rates as a public option on the health insurance exchanges could place as many as 55% of rural hospitals.
On July 11, the Centers for Medicare & Medicaid Services issued its calendar year 2020 proposed rule for the home health prospective payment system.
Medicare fee-for-service providers can sign up to participate in a pilot program allow clinicians to access a patient’s Medicare claims data for treatment purposes without logging into a separate application.
The Centers for Medicare & Medicaid Services yesterday projected that the average basic premium for a Medicare Part D prescription drug plan will decline from $32.50 in 2019 to $30 in 2020.
Medicare Administrative Contractors should begin accepting modifier codes for appropriate use criteria on Medicare claims for advanced diagnostic imaging on Jan. 1.